Evidence map›Paper›PMID 32672002›Full record

ArticleCancer reports (Hoboken, N.J.)2020

Role of the Wnt signaling pathway in keratoacanthoma.

Sarita Joshi, Paula M De Angelis, Manuela Zucknick, Aasa R Schjølberg, Solveig Norheim Andersen, Ole Petter F Clausen

Open access · hybridAbstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Role of the Wnt signaling pathway in keratoacanthoma.Cancer reports (Hoboken, N.J.) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sarita JoshiDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-2853-1626
Paula M De AngelisDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Manuela ZucknickOslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Aasa R SchjølbergDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Solveig Norheim AndersenInstitute of Clinical Medicine, Department of Pathology, Akershus University Hospital, Lørenskog, Norway.
Ole Petter F ClausenDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NOAkershus University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKeratoacanthoma (KA) has a unique life cycle of rapid growth and spontaneous regression that shows similarities to the hair follicle cycle, which involves an active Wnt signaling during physiological regeneration. We analyzed the expression of the Wnt signaling proteins β-catenin, Lef1, Sox9, and Cyclin D1 in young and old human KAs to investigate a possible role for Wnt signaling in KAs.

aimTo investigate the role of the Wnt/β-catenin signaling pathway in human KAs. METHODS AND

resultsFormalin-fixed, paraffin-embedded tissue samples of 67 KAs were analyzed for protein expression using immunohistochemistry. The majority of KAs were positive for Sox9 and Cyclin D1 but not for nuclear-localized β-catenin or Lef-1. No significant differences in protein expressions were seen between young and old KAs. However, we found a significant association between Ki67 and Cyclin D1 proteins (P= .008).

conclusionsThe Wnt signaling pathway does not appear to play a significant role in the biogenesis of human KA. Sox9 overexpression may be indicative of inhibition of Wnt signaling. Sox-9 and Cyclin D1 are proliferation markers that are most likely transactivated by alternate signaling pathways.

Indexed as

beta CateninCyclin D1HumansKeratoacanthomaKi-67 AntigenLymphoid Enhancer-Binding Factor 1SOX9 Transcription FactorWnt Signaling Pathwaybeta CateninCCND1 protein, humanCTNNB1 protein, humanCyclin D1Ki-67 AntigenLEF1 protein, humanLymphoid Enhancer-Binding Factor 1SOX9 protein, humanSOX9 Transcription Factorbiomarkerscarcinogencell biologyheterogeneitypathologypathway analysis

Identifiers

PMID32672002
PMCPMC7941577
OpenAlexW2985189255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.